Allianz Asset Management
OSIR

Allianz Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Allianz Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-22,000
Closed -$222K – 1920
2013
Q2 		$222K Buy
+22,000
New +$231K ﹤0.01% 1612

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Allianz Asset Management's OSIR Position: Q3 2013 in Review

Allianz Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2013, closing a stake of 22,000 shares — an estimated $222K sold.

Allianz Asset Management first reported a position in OSIR in Q2 2013 and held it in 1 quarter. The position peaked at $222K in Q2 2013. 64 funds tracked by Wall St. Rank hold OSIR as of Q3 2013.

  • Allianz Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • Allianz Asset Management sold 22,000 Osiris Therapeutics, Inc. Common Stock shares in Q3 2013, an estimated $222K.
  • Allianz Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • Allianz Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $222K in Q2 2013.
  • 64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2013.

Based on Allianz Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.